Search

everythinglearnresearchcommunity

for

Search:↓

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

A girl initially thought to have a psychiatric disorder was later found to have a lupus-related condition, which improved with proper treatment.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Valproic acid and carbamazepine do not change biotin or biotinidase levels but may lower zinc levels, still within normal range.

Poor sleep is linked to a higher risk of developing and worsening urinary problems in men.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

PCOS lowers quality of life, causing issues like obesity, infertility, and menstrual problems.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

New method uses hair follicle cells to estimate human body clock phase, potentially improving sleep disorder diagnosis.

Changing the diet of mice lacking the enzyme CBS can affect symptoms related to the genetic condition.

Combining mood stabilizers with antipsychotics is more effective for treating children with bipolar disorder than using mood stabilizers alone.

Almost all patients with chronic kidney disease not yet on dialysis have at least one skin problem.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Finasteride affects SRD5A2 gene pattern, possibly causing lasting side effects.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

A newborn with congenital syphilis had unusual hair loss possibly caused by the infection.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.